Objectives

After participating in this educational activity, attendees should be able to:

1| Define LADA and distinguish from other forms of diabetes
2| Identify risk factors and clinical features of LADA
3| Describe the pathophysiology and immunological basis of LADA
4| Review current guidelines for diagnosing, monitoring and treatment of LADA
5| Use in clinical practice as applicable with emphasis on interprofessional collaboration

 

Presenter(s): 
Kathryn Higgins, PharmD
PGY1 Community Based Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Kathryn Higgins, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
04/28/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours

Please login or register to take this course.